Ann: Australian Sales Update, page-15

News as expected, mostly we knew they won’t be able to sale 5 units @ the end of the year, we know the track record..

positives: @ least demo starting soon in US even though it might take quite long time before hear anything about it cause Geman lab started demo since April/ May still no updates on the outcome, if that is the case , US might take another 6 months to hear updates.. However, when and if US outcome is good, @ least 3 months after FDA approval, we might get somewhere because if product is validated overseas Australia  definately follows.

Negative: Eventhough they can’t sell on time why didn’t  they clear regulatory hurdles by clearing CE Mark & 501 K, this alone takes 3 to 6 months. They should promptly apply and secure approvals so that machines are allowed to sale overseas. Australia will ride the bandwagon when they see other countries using it, that how we got our OPAL card.

Even iphone Australia didn’t buy first &  if it was marketed here first probably SteveJobs might have failed, my guess.

Share market is always a share market, if you desperate sell now but if you want to make few bucks in a years time buy now, its cheap, might be more cheaper.. I just hope they don’t raise cap under 10c with in 6 months and its unlikely cash flow in early 2020 if it is slow progress like this.. AGM 2018, leadership change less likely unless some one from top 20 stands up .. so my biggest worry is they are very slow @ doning other things Forget the sale .Let’s say good bye this year  & hope they can crack in early next year, now is holiday season, who cares about urine

they all should concentrate on US not Australia, they should apply 501K ASAP, get CE mark ASAP.. wheels are in motion but slow and rough road ahead.. but if you are holding quite sometime,  selling now is not the best idea as far as i’m concerned, if I sell now, all I get is 6 months worth of 50 games Powerball, do you think I have more chance in Powerball than LBT, have to be miracle!!! Good Bye